Epilepsy develops in about 1% of people. The decision to start antiepileptic drug treatment is a diffucult one. It must be based on the risk-benefit ratio; subsequently, questions must be addressed regarding with which drug to use, and for how long. Finally, criteria for terminating treatment must be explained to the patient from the onset of treatment

Starting and stopping treatment.

SPECCHIO, LUIGI MARIA
2008-01-01

Abstract

Epilepsy develops in about 1% of people. The decision to start antiepileptic drug treatment is a diffucult one. It must be based on the risk-benefit ratio; subsequently, questions must be addressed regarding with which drug to use, and for how long. Finally, criteria for terminating treatment must be explained to the patient from the onset of treatment
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11369/10340
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact